UniSa - IRIS Institutional Research Information System

AMBONI, Marianna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.738
EU - Europa 1.974
AS - Asia 1.682
SA - Sud America 265
OC - Oceania 24
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.701
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.705
SG - Singapore 657
CN - Cina 490
RU - Federazione Russa 391
IT - Italia 373
UA - Ucraina 337
BR - Brasile 243
DE - Germania 227
IE - Irlanda 208
TR - Turchia 170
SE - Svezia 142
VN - Vietnam 137
KR - Corea 111
EE - Estonia 107
FI - Finlandia 60
GB - Regno Unito 55
HK - Hong Kong 53
FR - Francia 23
CA - Canada 22
IN - India 21
AU - Australia 14
CZ - Repubblica Ceca 14
JP - Giappone 13
NL - Olanda 10
NZ - Nuova Zelanda 10
AR - Argentina 8
AT - Austria 8
BD - Bangladesh 5
BE - Belgio 5
EU - Europa 5
IL - Israele 5
KE - Kenya 4
MX - Messico 4
PL - Polonia 4
VE - Venezuela 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
JM - Giamaica 3
PK - Pakistan 3
CO - Colombia 2
EC - Ecuador 2
ID - Indonesia 2
IQ - Iraq 2
IR - Iran 2
MA - Marocco 2
NP - Nepal 2
PE - Perù 2
UZ - Uzbekistan 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BW - Botswana 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HR - Croazia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PY - Paraguay 1
RO - Romania 1
SV - El Salvador 1
TN - Tunisia 1
Totale 8.701
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.105
Princeton 518
Chandler 509
Wilmington 468
Jacksonville 429
Singapore 250
Houston 247
Woodbridge 201
Dublin 198
Ashburn 193
Izmir 165
Dong Ket 136
Nanjing 112
Moscow 109
Tallinn 107
Andover 104
Beijing 91
Boardman 85
Salerno 69
Pellezzano 64
Düsseldorf 55
Norwalk 53
Hong Kong 48
Dearborn 44
Shenyang 43
Nanchang 39
Fairfield 34
Mestre 34
Naples 33
Hebei 29
Redwood City 26
Jiaxing 25
Changsha 19
Rome 18
Tianjin 18
São Paulo 17
Milan 16
Pune 16
San Diego 16
Dallas 14
Nuremberg 14
Washington 14
Guangzhou 11
West Jordan 10
Rio de Janeiro 9
Belo Horizonte 8
Cambridge 7
Jinan 7
Santa Maria A Vico 7
Wuhan 7
Council Bluffs 6
Dormagen 6
Fuzhou 6
Hefei 6
Napoli 6
San Francisco 6
Amsterdam 5
Brasília 5
Brussels 5
Carapicuíba 5
Dhaka 5
Fukushima 5
Guarulhos 5
Hangzhou 5
Kunming 5
Los Angeles 5
Ribeirão Preto 5
Sant'arpino 5
Sydney 5
Auckland 4
Brno 4
Casoria 4
Frankfurt am Main 4
Lappeenranta 4
Nairobi 4
Osaka 4
Padova 4
Santa Clara 4
Seattle 4
Shanghai 4
Zhengzhou 4
Anápolis 3
Betim 3
Canzo 3
Caserta 3
Curitiba 3
Melbourne 3
New York 3
Orange 3
Osasco 3
Ottawa 3
Porto Alegre 3
Sorocaba 3
São Bernardo do Campo 3
São José dos Campos 3
Tel Aviv 3
Wellington 3
Adelaide 2
Ankara 2
Assago 2
Totale 6.054
Salva come PNG Salva come JPEG
Nome #
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 139
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 133
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 129
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 127
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 125
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 110
Increased bilirubin levels in de novo Parkinson's disease 109
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 106
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 99
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 99
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 97
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 96
Gender and non motor fluctuations in Parkinson's disease: A prospective study 94
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 93
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 91
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 91
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 91
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 91
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 89
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 89
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 88
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 88
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 86
Quitting smoking: An early non-motor feature of Parkinson's disease? 84
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 84
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 84
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 84
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 81
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 81
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 81
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 80
Abnormal eating behaviors in progressive supranuclear palsy. 79
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 79
Bisphenol A glucuronidation in patients with Parkinson's disease 77
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. 76
Music Therapy for Motor and Nonmotor Symptoms of Parkinson's Disease: A Prospective, Randomized, Controlled, Single-Blinded Study 76
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 75
Comment on Szewczyk-Krolikowski et al.: The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort 75
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 75
Uric acid relates to dopamine transporter availability in Parkinson's disease. 74
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system 74
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 74
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 74
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 74
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 73
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 73
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 73
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 72
Parkinson’s disease and the spectrum of Lewy body disease 72
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 71
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 69
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 68
Resting brain networks in patients with Parkinson's disease and freezing of gait 67
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients. 67
Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion 67
Caratteristiche Cliniche 67
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 66
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 65
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 64
Ropinirole as a treatment of restless legs syndrome in patients on chronichemodialysis: an open randomized crossover trial versus levodopa sustainedrelease 63
Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease 62
Neuropsychological correlates of theory of mind in patients withearly Parkinson's disease. 62
Cognitive contributions to gait and falls: Evidence and implications 62
null 61
The "eye of the tiger" sign in pure akinesia with gait freezing. 61
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 61
Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson’s disease 61
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. 60
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 60
Classifying Different Stages of Parkinson’s Disease Through Random Forests 60
Freezing of gait and executive functions in patients with Parkinson's disease. 59
Hemi-restless legs syndrome induced by clebopride 59
Apathy in Parkinson's disease: differences between caregiver's report and self-evaluation 58
Exercise dependence induced by pramipexole in Parkinson's Disease-a case report. 57
Mild cognitive impairment in drug-naive patients with PD is associated withcerebral hypometabolism 57
Future thinking in Parkinson's disease: An executive function? 57
Comparative neuropsychological profile of pathological gambling, hypersexuality and compulsive eating in Parkinson’s disease. 57
Ropinirole as treatment of restless leg sindrome in patients on chrnic hemodyalisis: an open randomized, crossover trial versus levodopa sustained release 56
Longitudinal Changes Of Dopamine Transporter In Early-Onset Parkin Disease Measured With 123Fr-Cit Spect 56
Resting-state brain networks in patients with Parkinson's disease and impulse control disorders 55
Neuropsychological Correlates Of Major Depressive Episode In Parkinson’s Diesease 55
Freezing of gait and executive functions in patients with Parkinson’s disease 55
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 55
Metabolomics in Parkinson's disease 55
Parkinsonism and essential tremor in a family with pseudo-dominant inheritance ofPARK2: an FP-CIT SPECT study 54
Frontal dysfunction contributes to the genesis of hallucinations in non-demented Parkinsonian patients 53
Serum IGF-1 is associated with cognitive functions in early, drug-naive Parkinson's disease 52
The use of smell identification test in Parkinson's disease in Italy: Preliminary data 52
Gait patterns and cognition in Parkinson's disease 52
Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson's disease 51
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 51
Reversible Pisa syndrome in patients with Parkinson's disease on rasagiline therapy. 50
Neuropsychiatric disturbances in parkinsonian patients with and without freezing of gait 50
Demenza nella malattia di Parkinson 50
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 49
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 49
Development of software tool for quantitative gait assessment in Parkinsonian patients with and without Mild Cognitive Impairment 48
Imaging of dopaminergic dysfunction with 123FP-CIT SPECT in eary-onset parkin disease 47
Cognitive correlates of “pure apathy” in Parkinson's disease 47
“Response to Apomorphine in early Parkinson’s disease”. 46
Totale 7.300
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.659
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020179 0 0 0 0 0 0 0 0 0 0 163 16
2020/2021722 3 55 62 0 107 60 83 6 68 3 95 180
2021/2022829 9 2 12 14 6 1 7 33 112 117 120 396
2022/20231.274 154 67 37 114 203 295 11 111 185 12 61 24
2023/2024772 44 105 40 42 29 90 25 63 35 57 108 134
2024/20251.649 78 20 31 180 80 182 273 203 320 263 19 0
Totale 9.090